|
|
|||||||||
Basic Science Investigation |
The Division of Radiological Sciences, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
Correspondence: For correspondence contact: Pilar Herrero, MS, Mallinckrodt Institute of Radiology, Washington University School of Medicine, Campus Box 8225, 510 S. Kingshighway Blvd., St. Louis, MO 63110. E-mail: herrerop{at}mir.wustl.edu
This feasibility study was undertaken to determine whether kinetic modeling in conjunction with small-animal PET could noninvasively quantify alterations in myocardial perfusion and substrate metabolism in rats. Methods: All small-animal PET was performed on either of 2 tomographs. Myocardial blood flow and substrate metabolism were measured in 10 male Zucker diabetic fatty rats (ZDF, fa/fa) and 10 lean littermates (Lean, Fa/+) using 15O-water, 1-11C-glucose, 1-11C-acetate, and 1-11C-palmitate. Animals were 12.0 ± 1.4-wk old. Results: Consistent with a type 2 diabetic phenotype, the ZDF animals showed higher plasma hemoglobin A1c, insulin, glucose, and free fatty acid (FFA) levels than their lean controls. Myocardial glucose uptake (mL/g/min) was not significantly different between the 2 groups. However, higher glucose plasma levels in the ZDF rats resulted in higher myocardial glucose utilization (nmol/g/min) (Lean, 629 ± 785, vs. ZDF, 1,737 ± 1,406; P = 0.06). Similarly, myocardial FFA uptake (mL/g/min) was not significantly different between the 2 groups, (Lean, 0.51 ± 28, vs. ZDF, 0.72 ± 0.19; P = not significant) However, due to higher FFA plasma levels, utilization and oxidation (nmol/g/min) were significantly higher in the ZDF group (Lean, 519 ± 462, vs. ZDF, 1,623 ± 712, P < .001; and Lean, 453 ± 478, vs. ZDF, 1,636 ± 730, P < .01). Conclusion: Noninvasive measurements of myocardial substrate metabolism in ZDF rats using small-animal PET are consistent with the expected early metabolic abnormalities that occur in this well-characterized model of type 2 diabetes mellitus. Thus, small-animal PET demonstrates significant promise in providing a means to link the myocardial metabolic abnormalities that occur in rat of disease with the human condition.
Key Words: metabolism diabetes mellitus fatty acids imaging PET
Related articles in JNM:
This article has been cited by other articles:
![]() |
K. I. Shoghi, B. N. Finck, K. B. Schechtman, T. Sharp, P. Herrero, R. J. Gropler, and M. J. Welch In Vivo Metabolic Phenotyping of Myocardial Substrate Metabolism in Rodents: Differential Efficacy of Metformin and Rosiglitazone Monotherapy Circ Cardiovasc Imaging, September 1, 2009; 2(5): 373 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Sinusas, F. Bengel, M. Nahrendorf, F. H. Epstein, J. C. Wu, F. S. Villanueva, Z. A. Fayad, and R. J. Gropler Multimodality Cardiovascular Molecular Imaging, Part I Circ Cardiovasc Imaging, November 1, 2008; 1(3): 244 - 256. [Full Text] [PDF] |
||||
![]() |
K. I. Shoghi, R. J. Gropler, T. Sharp, P. Herrero, N. Fettig, Y. Su, M. S. Mitra, A. Kovacs, B. N. Finck, and M. J. Welch Time Course of Alterations in Myocardial Glucose Utilization in the Zucker Diabetic Fatty Rat with Correlation to Gene Expression of Glucose Transporters: A Small-Animal PET Investigation J. Nucl. Med., August 1, 2008; 49(8): 1320 - 1327. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-M. Wu, G. Sui, C.-C. Lee, M. L. Prins, W. Ladno, H.-D. Lin, A. S. Yu, M. E. Phelps, and S.-C. Huang In Vivo Quantitation of Glucose Metabolism in Mice Using Small-Animal PET and a Microfluidic Device J. Nucl. Med., May 1, 2007; 48(5): 837 - 845. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |